Cefiderocol for Stenotrophomonas maltophilia prosthetic joint infection: a case report.
Ther Adv Infect Dis
; 10: 20499361231174292, 2023.
Article
in En
| MEDLINE
| ID: mdl-37229181
ABSTRACT
Treatment of Stenotrophonomas maltophilia infections is difficult due to its predilection to form biofilms and susceptibility to a limited number of antibiotics. We report a case of S. maltophilia-associated periprosthetic joint infection successfully treated with a combination of the novel therapeutic agent, cefiderocol, and trimethoprim-sulfamethoxazole after debridement and implant retention.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Ther Adv Infect Dis
Year:
2023
Document type:
Article
Affiliation country:
United States